GSK calls it quits on trade group BIO for 2025, following exits by Takeda, UCB and more

GSK calls it quits on trade group BIO for 2025, following exits by Takeda, UCB and more

Submitted by admin on November 10, 2024 - 9:33pm
Source: 
Fierce Pharma
News Tags: 
GSK
BIO
Pfizer
Takeda
UCB Pharma
Headline: 
GSK calls it quits on trade group BIO for 2025, following exits by Takeda, UCB and more
snippet: 

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), following a string of exits by companies including Pfizer, UCB, WuXi AppTec and Takeda.

Do Not Allow Advertisers to Use My Personal information